Crassula Launches Q-Niflex — a Joint & Cartilage-Health Dietary Supplement Powered by Integria Care’s QuanticSphere Delivery Platform

Indore, India — Crassula LLC has launched Q-Niflex, a dietary supplement engineered for joint comfort, mobility, and cartilage support. Introduced at an event in Indore, Q-Niflex is the first finished consumer product to bring Integria Care’s QuanticSphere delivery platform to the Indian supplement market, pairing a Crassula-developed formulation with Integria Care’s PQNS delivery technology.

The launch reflects a two-part model behind the product. Integria Care supplies the delivery science — the QuanticSphere platform and its PQNS technology. Crassula LLC developed the finished blend and manufactures the consumer dosage form. Q-Niflex is where the two meet: an Integria Care delivery architecture inside a Crassula-formulated joint-health supplement.

The Architecture Behind Q-Niflex

QuanticSphere is Integria Care’s human-health delivery platform, and its core technology is PQNS (Phytosome Quantum Nano Sphere) — a cationic phospholipid vesicular delivery system (Patent Pending 202521095813). PQNS engineers bioactives into nano-scale phospholipid vesicles, 100–200 nm in size, designed to shield sensitive compounds from degradation in the digestive tract and support efficient transport across biological membranes.

Q-Niflex maps that delivery architecture to a specific set of biological functions: joint comfort, mobility, and cartilage support. Rather than relying on higher doses to compensate for poor absorption, the formulation is engineered to deliver its bioactives more efficiently — the QuanticSphere approach of improving uptake at the point of delivery rather than simply increasing the amount taken.

Addressing the Absorption Challenge

Many joint- and wellness-oriented bioactives are poorly absorbed in conventional form, which can require larger doses to reach meaningful levels in the body. PQNS is designed to improve ingredient transport across biological membranes, maintain stability in the gastrointestinal environment, and support sustained availability — with attention to digestive comfort and everyday tolerability that supports long-term use.

The platform’s safety architecture is built in by design: lower effective loads, sustained rather than spiking availability, no synthetic bioenhancers (no piperine), and GRAS-status phospholipid and biopolymer carriers that are fully biodegradable.

Expert Perspectives at the Launch

Scientists from Integria Care, which developed the QuanticSphere platform, spoke to the delivery science inside Q-Niflex.

Dr. Bhawana Gupta, Chief Scientific Officer, Integria Care, described the mechanism:

“PQNS is engineered to protect bioactives and improve how efficiently they are delivered. By encapsulating ingredients in nano-scale, phospholipid-based vesicles, the technology maintains stability while supporting consistent uptake — the same delivery architecture now built into Q-Niflex.”

Dr. Lavleen Gupta, Executive Director, Science & Innovation, Integria Care, addressed the broader platform:

“QuanticSphere is a modular platform, not a single-product technology. Q-Niflex is one application, focused on joint and mobility support. The same Integria technology can be deployed across many nutritional categories as we continue to expand.”

Health and nutrition professionals attending the event noted the growing interest in better-absorbed, everyday joint-support nutrition and the role that delivery technology can play in it.

A Platform for Future Products

QuanticSphere is designed as a modular, scalable platform capable of supporting a wide range of bioactives — vitamins, minerals, botanical extracts, and other nutritional compounds. Integria Care continues to develop the platform and its technology library, while Crassula LLC plans to expand its QuanticSphere-powered product line across additional wellness categories, with Q-Niflex as the first entry.

With this launch, Integria Care’s delivery science and Crassula LLC’s formulation and manufacturing come together in a finished supplement built on a simple premise: better delivery, engineered by design — engineered by science, powered by PQNS.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Integria Care Integria Care develops the QuanticSphere delivery platform and the PQNS technology, supplying advanced delivery science and finished B2B blends to brand owners and manufacturers. www.integriacare.com · info@integriacare.com

About Crassula LLC Crassula LLC develops and manufactures finished consumer supplement formulations, including Q-Niflex, built on Integria Care’s QuanticSphere delivery technology.